Joshua M. Eizen - 29 Sep 2022 Form 3 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Signature
/s/ Lucy Day, Attorney-in-Fact for Joshua M. Eizen
Issuer symbol
ANTX
Transactions as of
29 Sep 2022
Transactions value $
$0
Form type
3
Filing time
05 Oct 2022, 18:21:41
Next filing
28 Oct 2022

No securities are beneficially owned.

Remarks:

General Counsel, Chief Legal Officer and Corporate Secretary Exhibit 24 - Power of Attorney